Protara Therapeutic shares owned by UBS Group
Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Protara Therapeutic
Tip: Access up to 7 years of quarterly data
All positions including Protara Therapeutic held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protara Therapeutic by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7k | 916 | 1.88 |
| 2023-09-30 | $201 | 121 | 1.67 |
| 2023-03-31 | $3.0k | 971 | 3.13 |
| 2022-12-31 | $6.2k | 2.3k | 2.68 |
| 2022-09-30 | $999 | 239 | 4.18 |
| 2022-06-30 | $4.0k | 1.3k | 3.15 |
| 2022-03-31 | $3.0k | 574 | 5.23 |
| 2021-06-30 | $999 | 99 | 10.10 |
| 2021-03-31 | $23k | 1.4k | 16.01 |
| 2020-12-31 | $16k | 661 | 24.21 |
| 2020-09-30 | $2.0k | 138 | 14.49 |
| 2020-06-30 | $20k | 670 | 29.85 |